Reduced dopamine turnover in the basal ganglia of depressed suicides

被引:76
作者
Bowden, C
Cheetham, SC
Lowther, S
Katona, CLE
Crompton, MR
Horton, RW
机构
[1] ST GEORGE HOSP, SCH MED, DEPT PHARMACOL & CLIN PHARMACOL, LONDON SW17 0RE, ENGLAND
[2] KNOLL PHARMACEUT RES & DEV, NOTTINGHAM NG1 1GF, ENGLAND
[3] UCL, SCH MED, DEPT PSYCHIAT, LONDON W1N 8AA, ENGLAND
[4] ST GEORGE HOSP, SCH MED, DEPT FORENS MED, LONDON SW17 0RE, ENGLAND
关键词
dopamine; homovanillic acid; DOPAC; depression; suicide; post-mortem brain tissue; antidepressant drug; basal ganglia;
D O I
10.1016/S0006-8993(97)00692-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have measured the concentrations of dopamine, and the dopamine metabolites homovanillic acid (HVA) and dihydroxyphenylacetic acid (DOPAC), in five brain regions from suicide victims with a firm retrospective diagnosis of depression, and matched controls. The suicides were divided into those free of antidepressant drugs and those in whom prescription of antidepressant drugs was clearly documented. DOPAC concentrations were significantly lower in caudate, putamen and nucleus accumbens of antidepressant-free suicides compared to controls. In antidepressant-treated suicides, lower concentrations of DOPAC were observed in the basal ganglia, reaching statistical significance in caudate. Lower DOPAC concentrations were largely restricted to those suicides who died by non-violent methods. There were no significant differences in dopamine and HVA concentrations in either suicide group compared to controls, although there was a trend for HVA concentrations to be lower in suicides. This study provides evidence for reduced dopamine turnover, as judged from reduced DOPAC levels, in depressed suicides, although we cannot exclude the possibility that this may be due to ingestion of toxic agents. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 27 条
  • [1] ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193
  • [2] CORRELATION BETWEEN CEREBROSPINAL-FLUID AMINE METABOLITES AND PSYCHOMOTOR ACTIVITY IN AFFECTIVE-DISORDERS
    BANKI, CM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1977, 28 (01) : 255 - 257
  • [3] DETERMINATION OF MONOAMINE AND MONOAMINE METABOLITES IN HUMAN BRAIN - POST-MORTEM STUDIES IN A GROUP OF SUICIDES AND IN A CONTROL GROUP
    BESKOW, J
    GOTTFRIES, CG
    ROOS, BE
    WINBLAD, B
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1976, 53 (01) : 7 - 20
  • [4] [H-3] SPIPERONE BINDING, DOPAMINE AND HVA CONCENTRATIONS IN PARKINSONS-DISEASE AND SUPRANUCLEAR PALSY
    BOKOBZA, B
    RUBERG, M
    SCATTON, B
    JAVOYAGID, F
    AGID, Y
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) : 167 - 175
  • [5] Dopamine D-1 and D-2 receptor binding sites in brain samples from depressed suicides and controls
    Bowden, C
    Theodorou, AE
    Cheetham, SC
    Lowther, S
    Katona, CLE
    Crompton, MR
    Horton, RW
    [J]. BRAIN RESEARCH, 1997, 752 (1-2) : 227 - 233
  • [6] BOWERS MB, 1969, INT J NEUROPHARMACOL, V8, P255
  • [7] BRAIN 5-HT2 RECEPTOR-BINDING SITES IN DEPRESSED SUICIDE VICTIMS
    CHEETHAM, SC
    CROMPTON, MR
    KATONA, CLE
    HORTON, RW
    [J]. BRAIN RESEARCH, 1988, 443 (1-2) : 272 - 280
  • [8] Cooper J.R., 1991, BIOCH BASIS NEUROPHA, P285
  • [9] NEUROTRANSMITTER RECEPTORS AND MONOAMINE METABOLITES IN THE BRAINS OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA AND DEPRESSION, AND SUICIDES
    CROW, TJ
    CROSS, AJ
    COOPER, SJ
    DEAKIN, JFW
    FERRIER, IN
    JOHNSON, JA
    JOSEPH, MH
    OWEN, F
    POULTER, M
    LOFTHOUSE, R
    CORSELLIS, JAN
    CHAMBERS, DR
    BLESSED, G
    PERRY, EK
    PERRY, RH
    TOMLINSON, BE
    [J]. NEUROPHARMACOLOGY, 1984, 23 : 1561 - 1569
  • [10] NEW TABLES FOR MULTIPLE COMPARISONS WITH CONTROL
    DUNNETT, CW
    [J]. BIOMETRICS, 1964, 20 (03) : 482 - &